EGFL7 and hepatocellular carcinoma: To fully evaluate the diagnostic value of Egfl7 in the early detection of HCC, we pooled the healthy individuals and the patients with CLD into a single control group named as the non-HCC individuals and investigated the efficacies of Egfl7 in distinguishing the patients with early HCC from these individuals.